Cargando…

Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies

PURPOSE OF REVIEW: The aim of this review was to summarize key developments in classification and diagnosis of the idiopathic inflammatory myopathies (IIMs). RECENT FINDINGS: The recently published European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oldroyd, Alexander, Chinoy, Hector
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2018
Materias:	MYOSITIS AND MYOPATHIES: Edited by Andrea Doria and Anna Ghirardello
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170146/ https://www.ncbi.nlm.nih.gov/pubmed/30138132 http://dx.doi.org/10.1097/BOR.0000000000000549

Ejemplares similares

Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis
por: Rothwell, Simon, et al.
Publicado: (2019)

Update on autoantibodies and related biomarkers in autoimmune inflammatory myopathies
por: Choi, May Y., et al.
Publicado: (2023)

Exploring challenges in the management and treatment of inclusion body myositis
por: Skolka, Michael P., et al.
Publicado: (2023)

Update on muscle imaging in myositis
por: Tan, Ai Lyn, et al.
Publicado: (2023)

Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry‐Based Study
por: Espinosa‐Ortega, Fabricio, et al.
Publicado: (2022)

Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
por: Che, Weng Ian, et al.
Publicado: (2021)

Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Novel myosin-based therapies for congenital cardiac and skeletal myopathies
por: Ochala, Julien, et al.
Publicado: (2016)

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case–control study
por: Pijnenburg, Luc, et al.
Publicado: (2023)

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis
por: Lilleker, James B, et al.
Publicado: (2019)

Development of the prediction model for hypertension in patients with idiopathic inflammatory myopathies
por: Qin, Li, et al.
Publicado: (2021)

Idiopathic inflammatory myopathies and hypertension: Possible involvement of hormonal factors
por: Armanini, Decio, et al.
Publicado: (2021)

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups
por: Rothwell, Simon, et al.
Publicado: (2019)

Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
por: Rothwell, Simon, et al.
Publicado: (2017)

Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies
por: Zhou, Danlei, et al.
Publicado: (2023)

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis
por: Wilkinson, Meredyth G Ll, et al.
Publicado: (2023)

Aberrant Muscle Antigen Exposure in Mice Is Sufficient to Cause Myositis in a Treg Cell–Deficient Milieu
por: Young, Nicholas A, et al.
Publicado: (2013)

Muscle Weakness in Myositis: MicroRNA‐Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies
por: Kinder, Travis B., et al.
Publicado: (2020)

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I
por: Zhang, Lu, et al.
Publicado: (2023)

Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease
por: Chen, Xixia, et al.
Publicado: (2023)

Intramuscular lesions in musculoskeletal MRI as a favourable prognostic sign in patients with anti-MDA5 antibody-positive dermatomyositis
por: Oto, Yohsuke, et al.
Publicado: (2023)

Severe case of rhabdomyolysis following jellyfish envenomation in the Mediterranean Sea
por: Buscetta, Giorgio, et al.
Publicado: (2023)

Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments
por: Kawahata, Kimito, et al.
Publicado: (2023)

Rescue combination treatment of anti-MDA5-associated ARDS with daratumumab
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria
por: To, Fergus, et al.
Publicado: (2019)

A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies
por: Oldroyd, Alexander, et al.
Publicado: (2019)

Recent advances in the immunogenetics of idiopathic inflammatory myopathy
por: Chinoy, Hector, et al.
Publicado: (2011)

Update in inclusion body myositis
por: Machado, Pedro, et al.
Publicado: (2013)

Update in juvenile myositis
por: Nistala, Kiran, et al.
Publicado: (2013)

Genetics in inclusion body myositis
por: Rothwell, Simon, et al.
Publicado: (2017)

Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods – a qualitative study
por: Oldroyd, Alexander, et al.
Publicado: (2020)

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort
por: Parker, Matthew J S, et al.
Publicado: (2019)

Exploring Road of Classification Criteria for Idiopathic Inflammatory Myopathy
por: Li, Yu-Hui, et al.
Publicado: (2018)

Investigating characteristics of idiopathic inflammatory myopathy flares using daily symptom data collected via a smartphone app
por: Oldroyd, Alexander G S, et al.
Publicado: (2022)

A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies
por: Oldroyd, Alexander G S, et al.
Publicado: (2021)

Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological study
por: Parker, Matthew J S, et al.
Publicado: (2018)

Progress report on development of classification criteria for adult and juvenile idiopathic inflammatory myopathies
por: Pilkington, Clarissa, et al.
Publicado: (2014)

Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies
por: Oldroyd, Alexander G S, et al.
Publicado: (2021)

Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients
por: Chung, Sang Wan, et al.
Publicado: (2021)

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
por: Bottai, Matteo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bqkak5rcuh8lepr1emojstpcfr